Formerly Summit Biosciences Inc. | KDD Email Format
Pharmaceutical ManufacturingKentucky, United States11-50 Employees
Summit Biosciences Inc., based in Lexington, Kentucky, operated as a contract development and manufacturing organization focused on intranasal drug-delivery. It provided capabilities to advance nasal spray products from concept through commercial production and ran a cGMP manufacturing facility in Lexington. In January 2024, Summit was acquired by Kindeva Drug Delivery, a global drug-device CDMO, integrating Summit's nasal-spray capabilities into a broader platform. Post-acquisition, the company serves pharmaceutical developers seeking intranasal delivery solutions across development stages. The combined entity remains within the pharmaceutical manufacturing sector and aligns with Kindeva's remit in drug-device combination products spanning pulmonary, nasal, injectable, and transdermal delivery. The Lexington site continues to anchor its regional manufacturing footprint.